Product Details
Product Sizes
| Size | List Price | Price | Cart |
|---|---|---|---|
| 500,000 Cells | $712.80 | $605.88 | Add to Cart |
Human Prostate Carcinoma Cells (DU 145) were derived from a prostate carcinoma patient. They were taken from a metastatic site in the brain of a 69 year old Caucasian male. DU 145 are not hormone-sensitive and do not express prostate-specific antigen (PSA). Cells are supplied in frozen vials with more than 5x10^5 cells/vial. Universal Full Growth Medium (TM001) is recommended to culture the cells. Cells are prepared and manufactured in an ISO 9001:2015 certified environment and ISO 5 cleanroom. Product Highlights: |
Supporting Products
| Name | Catalog # | Size |
|---|---|---|
| Universal Coating Solution | AC002 | 20 ml |
| Universal Detachment Solution | AD002 | 100 ml |
| Universal Full Growth Medium | TM001 | 500 ml |
| Universal Neutralization Buffer | NB001 | 100 ml |
- Product Reviews- - Rating:
Leave a review for this product and you could be eligible for a $10 Starbucks gift card.
- Product Publications
Product Publications
If you've used this product in a publication, let us know. Email pshuster@neuromics.com, with the publication details and you could be eligible for an Amazon gift card.
- Related Products
Related Products
Name Catalog # Size GFP Expressing Human Prostate Carcinoma Cells (DU 145) TR03-GFP 500,000 Cells Human Prostate Carcinoma Cells (LNCaP) LNC001 500,000 Cells Human Prostate Carcinoma Cells (PC-3) PC001 500,000 Cells Human Prostate Carcinoma Cells (VcaP) VC001 500,000 Cells RFP Expressing Human Prostate Carcinoma Cells (DU 145) TR03-RFP 500,000 Cells
Images
DU 145 cells were incubated with diluted primary antibodies KRT18 and KRT19, then with fluorescent secondary antibodies (anti-mouse Cy2 and anti-rabbit Cy3) and mounted using iBright medium (SF40000).
DU 145 cells were incubated with diluted primary antibodies KRT18 and KRT19, then with fluorescent secondary antibodies (anti-mouse Cy2 and anti-rabbit Cy3) and mounted using iBright medium (SF40000).